Company: LCTX
Filing Date: 2025-05-01
Form Type: 8-K
Source: 0000950170-25-061466
Chunk: 2

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-05-01
Form: 8-K
Item: Item 8.01
Chunk 2
---
 are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Lineage undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                          Lineage Cell Therapeutics, Inc.          
  Date:      May 1, 2025      By:         /s/ George A Samuel III                  
                              Name:       George A. Samuel III